1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
(
- Contribution to journal › Article
-
Mark
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
(
- Contribution to journal › Article
-
Mark
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Highly Accurate Blood Test for Alzheimer's Disease Comparable or Superior to Clinical CSF Tests
(
- Contribution to journal › Article
-
Mark
Biomarker-based staging of Alzheimer disease : rationale and clinical applications
(
- Contribution to journal › Scientific review
-
Mark
Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease
(
- Contribution to journal › Article
-
Mark
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Novel avenues of tau research
(
- Contribution to journal › Scientific review
- 2023
-
Mark
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
(
- Contribution to journal › Article